| (Values in U.S. Thousands) | Jun, 2016 | Jun, 2015 | Jun, 2014 | Jun, 2013 | Jun, 2012 |
| Sales | 14,840 | 13,160 | 14,690 | 2,740 | 5,520 |
| Sales Growth | +12.77% | -10.42% | +436.13% | -50.36% | -16.99% |
| Net Income | -100,780 | -90,850 | -57,900 | -63,200 | -52,300 |
| Net Income Growth | -10.93% | -56.91% | +8.39% | -20.84% | -28.56% |
Unilife Corporation (UNIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Unilife Corporation is a medical device company based in U.S., focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. The primary target customers for the Company's products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife's main product is the Unifill ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with injectable drugs and vaccines. Unilife Corporation has FDA-registered medical device manufacturing facilities in Pennsylvania.